Troponin I phosphorylation in the normal and failing adult human heart

Circulation

Volumn 96, Issue 5, 1997, Pages 1495-1500

  Bodor, Geza S ^a,d   Oakeley, Annette E ^b   Allen, Paul D ^c   Crimmins, Dan L ^d   Ladenson, Jack H ^d   Anderson, Page A W ^b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

Calcium; Cardiomyopathy; Heart failure; Myocardial contraction; Myocardium

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALKALINE PHOSPHATASE; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; MONOCLONAL ANTIBODY; MUSCLE PROTEIN; PROTEIN KINASE C; TROPONIN I;

ADULT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FETUS; HEART CONTRACTION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE WALL; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0030773407     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.5.1495     Document Type: Article

References (45)

1. Wolff MR, Buck SH, Stoker SW, Greaser ML, Mentzer RM. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies. J Clin Invest. 1996;98:167-176.
2. Alpert NR, Gordon MS. Myofibrillar adenosine triphosphate activity in congestive heart failure. Am J Physiol. 1962;202:940-946.
3. Pagani ED, Alousi AA, Grant AM, Older TM, Dziuban SW Jr, Allen PD. Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ Res. 1988;63:380-385.
4. Mercadier J-J, Bouveret P, Gorza L, Schiaffino S, Clark WA, Zak R, Swynghedauw B, Schwartz K. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ Res. 1983;53: 52-62.
5. Boheler KR, Carrier L, de la Bastie D, Allen PD, Komajda M, Mercadier JJ, Schwartz K. Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing adult hearts. J Clin Invest. 1991;88: 323-330.
6. Sasse S, Brand NJ, Kyprianou P, Dhoot GK, Wade R, Arai M, Periasamy M, Yacoub MH, Barton PJR. Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res. 1993;72:932-938.
7. Hunkeler NM, Kullman J, Murphy AM. Troponin I isoform expression in human heart. Circ Res. 1991;69:1409-1414.
8. Margossian SS, White HD, Caulfield JB, Norton P, Taylor S, Slaytor HS. Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy: identification of a causal agent for impaired myocardial function. Circulation. 1992;85: 1720-1733.
9. Anderson PAW, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in humans: a comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ Res. 1991;69:1226-1233.
10. Wattanapermpool J, Guo X, Solaro RJ. The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated. J Cell Cardiol. 1995;27:1383-1391.
11. 2+-stimulated Mg-ATPase of reconstituted actomyosin S-1. J Biol Chem. 1995;270:25445-25454.
12. Jideama NM, Noland TA Jr, Raynor RL, Blobe GC, Fabbro D, Kazanietz MG, Blumberg PM, Hannun YA, Kuo JF. Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J Biol Chem. 1996;271:23277-23283.
13. Venema RC, Kuo JF. Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin Mg-ATPase. J Biol Chem. 1993;268:2705-2711.
14. Wolff MR, Whitesell LF, Moss RL. Calcium sensitivity of isometric tension is increased in canine experimental heart failure. Circ Res. 1995;76:781-789.
15. Anderson PAW, Oakeley AE. Immunological identification of five troponin T isoforms reveals an elaborate maturational troponin T profile in rabbit myocardium. Circ Res. 1989;65:1087-1093.
16. Puceat M, Hilal-Dandan H, Strulovivi B, Brunton LL, Brown JH. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem. 1994;269: 16938-16944.
17. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem. 1992;38:2203-2214.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
19. Schachat FH, Bronson DD, McDonald OB. Heterogeneity of contractile proteins. J Biol Chem. 1985;260:1108-1113.
20. Pluskal MG, Prezkop MB, Kavonian MR, Vecoli C, Hicks DA. Immobilon PVDF transfer membrane: a new membrane substrate for Western blotting of proteins. Biotechniques. 1986;4:272-283.
21. Holroyde MJ, Howe E, Solaro RJ. Modification of calcium requirements for activation of cardiac myofibrillar ATPase by cyclic AMP dependent phosphorylation. Biochim Biophys Acta. 1979;586: 63-69.
22. Bell RM, Hannun Y, Loomis C. Mixed micelle assay of protein kinase C. Methods Enzymol. 1986;124:353-359.
23. Edes I, Kranias EG. Phospholamban and troponin I are substrates for protein kinase C in vitro but not in intact beating guinea pig hearts. Circ Res. 1990;67:394-400.
24. Morano M, Zacharzowski U, Maier M, Lange PE, Aleximeskishvili V, Haase H, Morano I. Regulation of human heart contractility by essential myosin light chain isoforms. J Clin Invest. 1996;98:467-473.
25. Moir AJG, Perry SV. The sites of phosphorylation of rabbit cardiac troponin I by adenosine 3′:5′-cyclic monophosphate-dependent protein kinase. Biochem J. 1977;167:333-343.
26. Mittmann K, Jaquet K, Heilmeyer LMG Jr. A common motif of two adjacent phosphoserines in bovine, rabbit and human cardiac troponin I. FEBS Lett. 1990;273:41-45.
27. Anderson PAW, Malouf NN, Oakeley AE, Pagani ED, Allen PD. Troponin T isoform expression in the normal and failing human left ventricle: a correlation with myofibrillar ATPase activity. Basic Res Cardiol. 1992;87:117-127.
28. Solaro RJ, Moir AJG, Perry SV. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature. 1976;262:615-616.
29. 2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy. Circulation. 1992;85:518-525.
30. 2+ in intact and skinned trabeculae from control and myopathic human hearts. J Clin Invest. 1988;82:1578-1582.
31. Schwinger RHG, Bohm M, Koch A, Schmidt U, Morano I, Eissner HJ, Uberfuhr P, Reichart B, Erdmann E. The failing human heart is unable to use the Frank-Starling mechanism. Circ Res. 1994;74: 959-969.
32. 1 receptor downregulation in heart failure. Circ Res. 1986;59:297-309.
33. 2 adrenergic receptor mediated adenylate cyclase stimulation in non-failing and failing human ventricular myocardium. Mol Pharmacol. 1989;35:295-303.
34. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the β adrenergic receptor pathway in the intact failing human heart: progressive receptor downregulation and subsensitivity to agonist response. Circulation. 1986;74:1290-1302.
35. Karliner JS, Scheinmen M. Adenylate cyclase activity coupled to the stimulatory guanine nucleotide binding protein in patients having electrophysiologic studies and either structurally normal hearts or idiopathic myocardial disease. Am J Cardiol. 1988;62: 1129-1139.
36. Denniss AR, Marsh JK, Quigg RJ, Gordon JB, Colucci WS. β-Adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts. Circulation. 1989;79:1028-1034.
37. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV, Fowler M, Ginsburg R. β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest. 1992;89:803-815.
38. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
39. Calderone A, Bouvier M, Li K, Juneau C, de Champlain J, Rouleau JL. Dysfunction of the β- and α-adrenergic systems in a model of congestive heart failure, the pacing-overdrive dog. Circ Res. 1991; 69:332-343.
40. Delehanty JM, Himura Y, Elam H, Hood WB Jr, Liang C-S. β-Adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content. Am J Physiol. 1994;266:H930-H935.
41. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homey CJ, Vatner SF, Vatner DE. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest. 1993;91:907-914.
42. Marzo KP, Frey MJ, Wilson JR, Liang BT, Manning DR, Lanoce V, Molinoff PB. β-Adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res. 1991;69:1546-1556.
43. Parker JD, Landzberg JS, Bittl JA, Mirsky I, Colucci WS. Effects of β-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle. Circulation. 1991;84: 1040-1048.
44. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046-1055.
45. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjaimarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1993;342:1441-1446.